Volume 92, Issue 1, Pages (July 2017)

Slides:



Advertisements
Similar presentations
Date of download: 11/12/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diet and Kidney Disease in High-Risk Individuals.
Advertisements

Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Chronic Kidney Disease in Diabetes
Volume 80, Issue 1, Pages (July 2011)
Copyright © 2012 American Medical Association. All rights reserved.
Volume 80, Issue 1, Pages (July 2011)
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Frederik Persson, Peter Rossing  Kidney International Supplements 
Volume 85, Issue 5, Pages (May 2014)
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
Volume 83, Issue 3, Pages (March 2013)
Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline  Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,
Volume 92, Issue 1, Pages (July 2017)
From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria  Paul E. De Jong, Barry M. Brenner  Kidney International 
Volume 93, Issue 4, Pages (April 2018)
Biomarkers in kidney fibrosis: are they useful?
Volume 79, Issue 12, Pages (June 2011)
Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration.
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets  David M. Spiegel, Kate Brady  Kidney.
Volume 80, Issue 9, (November 2011)
Volume 93, Issue 1, Pages (January 2018)
Chronic Kidney Disease in Diabetes
Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.
Volume 80, Issue 1, Pages (July 2011)
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 80, Issue 2, Pages (July 2011)
Volume 86, Issue 4, Pages (October 2014)
Your Kidneys May Outlive You
Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis  Xiaole Su, MD, Lu Zhang, MD, Jicheng Lv, MD, PhD, Jinwei Wang, PhD,
Volume 91, Issue 2, Pages (February 2017)
Volume 79, Issue 12, Pages (June 2011)
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Volume 93, Issue 3, Pages (March 2018)
Volume 84, Issue 5, Pages (November 2013)
Comorbidity and confounding in end-stage renal disease
Dietary phosphorus is associated with greater left ventricular mass
Volume 83, Issue 5, Pages (May 2013)
Volume 82, Issue 3, Pages (August 2012)
Volume 91, Issue 1, Pages (January 2017)
Volume 70, Issue 11, Pages (December 2006)
Gary C.W. Chan, Sydney C.W. Tang  Kidney International 
Bariatric surgery is associated with improvement in kidney outcomes
Volume 79, Issue 9, Pages (May 2011)
Volume 85, Issue 6, Pages (June 2014)
U-shaped effect of eGFR and mortality
Volume 76, Issue 10, Pages (November 2009)
Volume 70, Issue 12, Pages (December 2006)
Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease  Joan C. Lo, Glenn M. Chertow, Alan S. Go, Chi-Yuan.
Beef Tea, Vitality, Creatinine, and the Estimated GFR
Volume 65, Issue 3, Pages (March 2004)
Volume 76, Issue 3, Pages (August 2009)
Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske 
Methods for guideline development
Volume 76, Issue 8, Pages (October 2009)
Neesh Pannu, Braden Manns, Helen Lee, Marcello Tonelli 
Prehypertension: is it relevant for nephrologists?
Volume 60, Issue 1, Pages (July 2001)
Volume 76, Issue 6, Pages (September 2009)
Volume 80, Issue 10, Pages (November 2011)
Volume 81, Issue 7, Pages (April 2012)
Volume 89, Issue 5, Pages (May 2016)
Volume 63, Pages S13-S16 (February 2003)
Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti 
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
Volume 83, Issue 5, Pages (May 2013)
Friends, social networks, and progressive chronic kidney disease
Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs.
Figure 1. (A) Composite renal outcome, (B) worsening kidney function, and (C) incident albuminuria by fasting glucose ... Figure 1. (A) Composite renal.
Volume 86, Issue 2, Pages (August 2014)
Jacob J.E. Koopman, MD, PhD  American Journal of Kidney Diseases 
Presentation transcript:

Volume 92, Issue 1, Pages 67-78 (July 2017) Renal function in relation to sodium intake: a quantitative review of the literature  Kyoko Nomura, Kei Asayama, Lotte Jacobs, Lutgarde Thijs, Jan A. Staessen  Kidney International  Volume 92, Issue 1, Pages 67-78 (July 2017) DOI: 10.1016/j.kint.2016.11.032 Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 1 Selection of studies. Kidney International 2017 92, 67-78DOI: (10.1016/j.kint.2016.11.032) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 2 Forest plot of mean difference (95% confidence intervals) of estimated glomerular filtration rate (eGFR) per 100 mmol/d increment in sodium intake derived from urinary or dietary measurements in 6 cross-sectional studies. Squares represent individual studies and have a size proportional to the inverse of the variance of the association size in each study. Number of participants (No.) and mean sodium intake in the low and high sodium exposure groups are given. If mean sodium intake was not reported, the upper and lower limits of the low and high sodium exposure groups were given instead. Detailed information on each study is available in Table 1. Kidney International 2017 92, 67-78DOI: (10.1016/j.kint.2016.11.032) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 3 Forest plot of odds ratios (95% confidence intervals) for albuminuria per 100 mmol/d increment in the estimated sodium intake in 8 cross-sectional studies. Squares represent individual studies and have a size proportional to the inverse of the variance of the effect size in each study. Number of participants (No.) and mean sodium intake in the low and high sodium exposure groups are given. If mean sodium intake was not reported, the upper and lower limits of the low and high sodium exposure groups were given instead. Detailed information, including outcome assessment and covariables adjusted, is available in Table 1. Kidney International 2017 92, 67-78DOI: (10.1016/j.kint.2016.11.032) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 4 Forest plot of relative risks (95% confidence intervals) for renal endpoints per 100 mmol/d increment in the estimated sodium intake in 5 cohort studies. Squares represent individual studies and have a size proportional to the inverse of the variance of the effect size in each study. Outcomes: CKD, chronic kidney disease; ESRD, end-stage renal disease; UACR, urinary albumin-to-creatinine ratio. Detailed information on each study is available in Table 2. Kidney International 2017 92, 67-78DOI: (10.1016/j.kint.2016.11.032) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 5 Forest plot of the percentage difference (95% confidence intervals) in estimated glomerular filtration rate (eGFR) or creatinine clearance between the high and low sodium intake groups rescaled to a 100 mmol/d difference in estimated sodium intake. Squares represent individual studies and have a size proportional to the inverse of the variance of the effect size in each trial. Detailed information on each study is available in Table 3. Kidney International 2017 92, 67-78DOI: (10.1016/j.kint.2016.11.032) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 6 Forest plot of the percentage difference (95% confidence intervals) in albuminuria between the high and low sodium intake groups rescaled to a 100 mmol/d difference in estimated sodium intake. Squares represent individual studies and have a size proportional to the inverse of the variance of the effect size in each trial. Detailed information on each study is available in Table 3. Outcomes: UACR, urinary albumin-to-creatinine ratio; UPCR, urinary protein-to-creatinine ratio. Kidney International 2017 92, 67-78DOI: (10.1016/j.kint.2016.11.032) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 7 Meta-regression analysis of the percentage difference in the renal outcome plotted versus the duration of the intervention in 6 trials. The regression line was drawn with 95% confidence intervals and weighted for the inverse of the variance of the effect sizes in individual studies. Circles have a size proportional to the number of participants. P denotes significance of the regression slope. Kidney International 2017 92, 67-78DOI: (10.1016/j.kint.2016.11.032) Copyright © 2017 International Society of Nephrology Terms and Conditions

Supplementary Figure 1 Funnel plot of mean difference (95% confidence intervals) in estimated glomerular filtration rate (eGFR) for a 100 mmol/day increment in the estimated sodium intake. Trial size was plotted against the difference in eGFR. Table 3 and Figure 5 provide detailed information on each study. Kidney International 2017 92, 67-78DOI: (10.1016/j.kint.2016.11.032) Copyright © 2017 International Society of Nephrology Terms and Conditions